Citadel Advisors
PAHC icon

Citadel Advisors’s Phibro Animal Health PAHC Stock Holding History

Citadel Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-400
Closed -$6.71K – 14953
2024
Q2 		$6.71K Sell
400
-1,700
-81% -$27.3K ﹤0.01% 13313
2024
Q1 		$27.2K Sell
2,100
-3,100
-60% -$37.2K ﹤0.01% 12783
2023
Q4 		$60.2K Buy
+5,200
New +$58.7K ﹤0.01% 11589
2023
Q3 		– Sell
-3,100
Closed -$42.5K – 14877
2023
Q2 		$42.5K Sell
3,100
-800
-21% -$11.5K ﹤0.01% 12000
2023
Q1 		$59.7K Buy
3,900
+1,600
+70% +$24.4K ﹤0.01% 11936
2022
Q4 		$30.8K Buy
+2,300
New +$30.8K ﹤0.01% 12716
2015
Q4 		– Sell
-1,000
Closed -$32K – 9060
2015
Q3 		$32K Buy
+1,000
New +$36.5K ﹤0.01% 7879

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors's PAHC Position: Q2 2026 in Review

Citadel Advisors opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 14,889 shares worth $468K. The stake represents ﹤0.01% of the portfolio and ranks #10025 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PAHC as recently as Q4 2025.

Citadel Advisors first reported a position in PAHC in Q2 2014 and has held it in 39 quarters since. The position peaked at $4.96M in Q1 2019. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Citadel Advisors held 14,889 shares of Phibro Animal Health worth $468K as of Q2 2026.
  • Phibro Animal Health was a new Citadel Advisors position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10025 holding.
  • Citadel Advisors first reported a position in Phibro Animal Health in Q2 2014 and has held it in 39 quarters since.
  • Citadel Advisors's Phibro Animal Health position peaked at $4.96M in Q1 2019.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.